Tofacitinib Tablet, Film Coated, Extended Release
Product Images NDC 70710-1353

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 70710-1353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (948821f3 1c49 4284 B8a7 4f2dd9dd23af 01)

FDA Label Image

Image (948821f3 1c49 4284 B8a7 4f2dd9dd23af 02)

FDA Label Image

Image (948821f3 1c49 4284 B8a7 4f2dd9dd23af 03)

FDA Label Image

Image (948821f3 1c49 4284 B8a7 4f2dd9dd23af 04)

FDA Label Image

Image (948821f3 1c49 4284 B8a7 4f2dd9dd23af 05)

FDA Label Image

Figure 5 (948821f3 1c49 4284 B8a7 4f2dd9dd23af 06)

FDA Label Image

Image (948821f3 1c49 4284 B8a7 4f2dd9dd23af 07)

FDA Label Image

Tofacitinib Extended-release Tablets, 11 mg (948821f3 1c49 4284 B8a7 4f2dd9dd23af 08)

FDA Label Image

Tofacitinib Extended-release Tablets, 22 mg (948821f3 1c49 4284 B8a7 4f2dd9dd23af 09)